TipRanks
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market
ABCL
AbCellera Biologics
RESEARCH TOOLSreports
Want to see ABCL full AI Analyst Report?

AbCellera Biologics (ABCL) Stock News & Sentiment

2,517 Followers
AbCellera Biologics Announces Oversubscribed $200 Million Offering
Premium
Company Announcements
AbCellera Biologics Announces Oversubscribed $200 Million Offering
1M ago
8K
ABCL
AbCellera Price Target Raised to $15 on Best-in-Class ABCL635 Phase 2 Data and Strategic Pipeline Momentum
Premium
Ratings
AbCellera Price Target Raised to $15 on Best-in-Class ABCL635 Phase 2 Data and Strategic Pipeline Momentum
1M ago
ABCL
AbCellera Earnings Call Balances Cash Strength With Risk
Premium
Company Announcements
AbCellera Earnings Call Balances Cash Strength With Risk
1M ago
ABCL
AbCellera to Report Phase 2 Menopause Therapy Data
Premium
Company Announcements
AbCellera to Report Phase 2 Menopause Therapy Data
1M ago
8K
ABCL
Analyst Brendan Smith Reiterates Buy on AbCellera, Citing Strong Liquidity and Upcoming Phase 2 Data for ABCL635 in Hot-Flash Market
Premium
Ratings
Analyst Brendan Smith Reiterates Buy on AbCellera, Citing Strong Liquidity and Upcoming Phase 2 Data for ABCL635 in Hot-Flash Market
2M ago
ABCL
AbCellera and Vertex launch autoimmune T-cell engager partnership
Premium
Company Announcements
AbCellera and Vertex launch autoimmune T-cell engager partnership
2M ago
8K
ABCL
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
Premium
Market News
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
2M ago
ABCL
NUVB
More ABCL News >

ABCL News on the Web

AbCellera advances new menopause antibody in clinical spotlight
TipRanks News
Bullish
Menopause Drug Breakthrough Sends AbCellera Stock Soaring
TipRanks News
Bullish
Insider Confidence Surge: Director Makes Bold Move on AbCellera Biologics
TipRanks News
Neutral
AbCellera (ABCL) Soars 64% as Drug Candidate Holds Huge Market Opportunity
Insider Monkey
Bullish
Top Executives Quietly Double Down on AbCellera Biologics Stock
TipRanks News
Neutral
Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
Insider Monkey
Neutral
AbCellera (ABCL) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
S&P 500 Holds 7,753 Below Record as Brent Hits $88.89 and the 10-Year Reaches 4.726% Before July CPI
TradingNEWS.com
Bullish

News Score - Last 7 Days

Very Positive
ABCL
Sector Average
Media Buzz
This Week6 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ABCL’s Media Buzz Sentiment?
6 articles about ABCL were published this week. In an average week, 3.5 articles are published.
    What is ABCL’s weekly average amount of articles?
    In an average week, 3.5 articles about ABCL are published.
      What is ABCL’s News Sentiment?
      100% of articles about ABCL were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CRLCharles River Labs
        DFTXDefinium Therapeutics
        AMRXAmneal Pharmaceuticals
        IOVAIovance Biotherapeutics
        HITIHigh Tide
        Showing the stocks with the most bullish news sentiment over the past week